Nomograms for predicting survival of patients with glioblastoma

tumor mass >2 cm (P <0.0001), and tumor platinum resistance (P <0.001), but it was not associated with tumor histologic grade and type, patient age, or preoperative serum cancer antigen 125 level. Patients with elevated serum CRP levels had lower overall 5-year survival than those with normal (≤1 mg/dl) serum CRP levels (58.5% vs 82.0%; P <0.001). Serum CRP… CONTINUE READING